1. Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer;Basser;Blood,1997
2. Erratum;Basser;Blood,1997
3. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer;Fanucchi;N Engl J Med,1997
4. Recombinant human thrombopoietin: Clinical experience and in vivo biology;Vadhan-Raj,1998
5. Recombinant human thrombopoietin (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecologic malignancy;Vadhan-Raj;Blood,1997